Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TACR1 | P25103 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19343573 | 0.80 | SLC6A9 (0.50) | SMN1; SMN2TDP1SLC6A9CYP2D6ALDH1A1 | |
| SCHEMBL19330992 | 0.78 | SMN1; SMN2 (0.49) | SMN1; SMN2TDP1CYP2D6SIGMAR1CYP3A4 | |
| SCHEMBL19330808 | 0.76 | KDM4E (0.56) | SMN1; SMN2TDP1CYP2D6ALDH1A1SIGMAR1 | |
| SCHEMBL23862834 | 0.72 | SLC6A9 (0.43) | SLC6A9CYP2D6ALDH1A1SIGMAR1CYP3A4 | |
| SCHEMBL23862875 | 0.70 | SLC6A9 (0.35) | SMN1; SMN2TDP1SLC6A9CYP2D6ALDH1A1 | |
| SCHEMBL6042035 | 0.68 | OPRL1 (0.73) | SMN1; SMN2TDP1ALDH1A1SIGMAR1POLB | |
| SCHEMBL19343289 | 0.67 | CYP2D6 (0.51) | SLC6A9CYP2D6ALDH1A1CYP3A4TSHR | |
| SCHEMBL19331312 | 0.67 | CYP2D6 (0.49) | CYP2D6ALDH1A1SIGMAR1CYP3A4TSHR | |
| SCHEMBL5765577 | 0.65 | OPRM1 (0.68) | — | |
| SCHEMBL5795228 | 0.65 | OPRM1 (0.68) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3426243-B1 | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF | RAZE THERAPEUTICS INC (US) | 2021-05-19 | — | — | EP | disclosed |